A patient with Lyme arthritis presenting in general practice

Practitioner

Volumn 257, Issue 1758, 2013, Pages 25-27

  Moßhammer, Dirk ^a,b   Hlobil, Harald ^c   Joos, Stefanie ^d   Reichert, Walter ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Practice of Family Medicine and Internal Medicine   (Germany)

^c Practice of Laboratory Medicine   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORRELIA BURGDORFERI; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GENERAL PRACTICE; HUMAN; LYME DISEASE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; SYNOVIAL FLUID;

BORRELIA BURGDORFERI; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENERAL PRACTICE; HUMANS; LYME DISEASE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 84875522367     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/LymeDisease/ EpidemiologicalData/lymLymeepidemiology/
2. Fingerle V. Lyme-Borreliose: Wissenswertes zum Vektor und die mikrobiologische Diagnostik. Der Mikrobiologe2011;3(21):83-92
3. Satz N. Klinik der Lyme-Borreliose. Hans Huber. Bern. 2010
4. RKI. Lyme-Borreliose: Analyse der gemeldeten Erkrankungsfälle der Jahre 2007 bis 2009 aus den sechs östlichen Bundesländern. Epidemiologisches Bulletin 2010;12:101-10
5. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med1987;107(5):725-31
6. Schmidt R, Kabatzki J, Hartung S, Ackermann R. Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects. Dtsch Med Wochenschr 1985;110(47):1803-7
7. Priem S, Munkelt K, Franz JK et al. Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey. Z Rheumatol2003;62(5):450-8
8. Krause PJ, Foley DT, Burke GS et al. Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg 2006;75(6):1090-4
9. Duray PH. Histopathology of clinical phases of human Lyme disease. Rheum Dis Clin North Am1989;15(4):691-710
10. Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci 1988;539:65-79
11. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect2004;10(12):1108- 32
12. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for lyme disease. Clin Infect Dis2008;47(2):188-95
13. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005;18(3):484-509
14. O'Connell S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis 2010;23(3):231-5
15. Strle F, Stanek G. Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol2009;37:51-110
16. www.eucalb.com
17. Akin E, McHugh GL, Flavell RA et al. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun1999;67(1):173-81
18. Craft JE, Grodzicki RL, Shrestha M et al. The antibody response in Lyme disease. Yale J Biol Med 1984;57(4):561-5
19. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis.FEMS Immunol Med Microbiol2007;49(1):13-21
20. Nau R, Christen HJ, Eiffert H. Lyme disease-current state of knowledge. Dtsch Arztebl Int2009;106(5):72-81
21. Kalish RA, Kaplan RF, Taylor E et al. Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis 2001;183(3):453-60